CareDx CDNA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Patient and digital solutions revenue | $15.96M+33.5% | $16.76M+47.1% | $15.41M+29.9% | $12.81M+19.2% | $11.95M+24.3% | |
| Testing services revenue | $91.4M+47.6% | $78.37M+22.8% | $72.17M+18.7% | $62.03M-12.5% | $61.92M+15.0% | |
| Total Revenue by Geography | ||||||
| Rest of World | $4.05M-15.9% | —— | —— | —— | $4.82M+20.1% | |
| United States | $113.65M+42.3% | $103.38M+25.8% | $95.06M+20.2% | $81.64M-7.2% | $79.87M+16.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CareDx break its business down?
- CareDx (CDNA) reports total revenue by product across 2 parts — Patient and digital solutions revenue and Testing services revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does CareDx's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CareDx's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
